Search
Akebia Therapeutics Inc
AKBAAdd to Watchlist
0.742USD
-0.023-3.01%
Close 10-29 16:00（ET）
205.62MMarket Cap
LossP/E TTM
Today
-3.01%
5 Days
+32.03%
1 Month
-16.25%
6 Months
-45.44%
Year to Date
-53.91%
1 Year
-64.67%
Key Figures
0.780Open
0.800High
362.27KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
0.765Prev. Close
0.737Low
280.83KTurnover
LossP/E Static
8.22P/B
0.00%Div Yield TTM
-6.10%ROA
2.32052wk High
0.03Volume Ratio
-69.41MNet Profit
277.11MShares
-0.0806EPS TTM
0.28Beta
-78.96%ROE
0.54252wk Low
18.69%Amplitude
81.13%Gross Margin
205.62MMarket Cap
-8.72Reward/Risk
4.73%Risk Rate
Akebia Therapeutics Inc's Score
-0.02vs previous score
Forecast8.33
Financial Health7.80
Technical5.89
Valuation Dimensions8.77
Institutional Confidence3.00
Risk Assessment3.51
Media Coverage
Coverage Level
Very Low
Very High
Negative
Analyst Rating
Akebia Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.03/-0.04
Revenue / Forecast
49.13M/48.86M
Akebia Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolAKBA
Number of employees181
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 6.49% |
| State Street Investment Management (US) | 4.33% |
| Vanguard Capital Management, LLC | 4.16% |
| Geode Capital Management, L.L.C. | 2.34% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 19.09% |
| Investment Advisor/Hedge Fund | 14.33% |
| Hedge Fund | 5.92% |
| Research Firm | 4.42% |
Related Instruments
+6.63%
+1.53%
+1.68%
+3.83%
+3.22%
+2.88%
+1.97%
+4.03%
+2.22%
+1.70%
+1.95%
+1.35%
+2.12%
+2.11%
-0.12%
+4.01%
+0.68%
-0.69%
+2.59%
+0.68%Popular Instruments
52397.000
+59.600 (+0.11%)
28762.900
-302.100 (-1.04%)
7646.400
-29.300 (-0.38%)
12797.000
-44.000 (-0.34%)
63044.000
-940.000 (-1.47%)
6148.900
-49.700 (-0.80%)
103.118
+0.716 (+0.70%)
348.910
+5.080 (+1.48%)
213.660
-1.720 (-0.80%)
3990.780
-30.170 (-0.75%)
FAQs
What is the current price of Akebia Therapeutics Inc (AKBA)?
The current price of Akebia Therapeutics Inc (AKBA) is 0.74.
What is the symbol of Akebia Therapeutics Inc?
The ticker symbol of Akebia Therapeutics Inc is AKBA.
What is the 52-week high of Akebia Therapeutics Inc?
The 52-week high of Akebia Therapeutics Inc is 2.56.
What is the 52-week low of Akebia Therapeutics Inc?
The 52-week low of Akebia Therapeutics Inc is 0.54.
What is the market capitalization of Akebia Therapeutics Inc?
The market capitalization of Akebia Therapeutics Inc is 205.62M.
Is Akebia Therapeutics Inc (AKBA) currently rated as Buy, Hold, or Sell?
According to analysts, Akebia Therapeutics Inc (AKBA) has an overall rating of Buy, with a price target of 3.92.
What is the Earnings Per Share (EPS TTM) of Akebia Therapeutics Inc (AKBA)?
The Earnings Per Share (EPS TTM) of Akebia Therapeutics Inc (AKBA) is -0.08.